Short stature and short trunk have been reported in thalassaemic patients.
We report a study on stature and body proportions in 476 patients (2-36 yea
rs old) with beta-thalassaemia major, followed in 12 Italian centres, Auxol
ogical data (standing height, sitting height, subischial leg length, target
height), haematological data (age at first transfusion, age at start of de
sferrioxamine [DFX] chelation, mean dose of DFX, ferritin values) and infor
mation regarding the presence of endocrine disorders and of bone lesions,we
re collected and analysed according to the age of the patients, in order to
investigate the natural history of the disproportion and the role of sider
osis, DFX toxicity and endocrine disorders. Our data indicate that about 18
% of thalassaemic patients exhibit short stature; disproportion between the
upper and lower body segments is present in 14%; however, a short trunk de
spite normal stature is present in another 40% of patients. This is due to
a spinal growth impairment which starts in infancy and progressively aggrav
ates. We think that a short trunk is peculiar to the disease itself; howeve
r, other factors such as hypogonadism, siderosis, or DFX-induced bone dyspl
asia are probably involved in aggravating the body disproportion in these p
atients.